Although exaggeration or amplification of symptoms is common in all illness, deliberate deception is rare. In settings associated with litigation/disability evaluation, the rate of malingering may be as high as 30%, but its frequency in clinical practice is not known. We describe the main characteristics of deliberate deception (factitious disorders and malingering) and ways that neurologists might detect symptom exaggeration. The key to establishing that the extent or severity of reported symptoms does not truly represent their severity is to elicit inconsistencies in different domains, but it is not possible to determine whether the reports are intentionally inaccurate. Neurological disorders where difficulty in determining the degree of willed exaggeration is most likely include functional weakness and movement disorders, post-concussional syndrome (or mild traumatic brain injury), psychogenic non-epileptic attacks and complex regional pain syndrome type 1 (especially when there is an associated functional movement disorder). Symptom amplification or even fabrication are more likely if the patient might gain benefit of some sort, not necessarily financial. Techniques to detect deception in medicolegal settings include covert surveillance and review of social media accounts. We also briefly describe specialised psychological tests designed to elicit effort from the patient.
- factitious disorders
- functional neurological symptoms
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Commissioned; externally peer reviewed by Jon Stone, Edinburgh, UK, and Alan Carson, Edinburgh, UK.
Read the full text or download the PDF:
Other content recommended for you
- Complex regional pain syndrome and functional neurological disorders – time for reconciliation
- Functional neurological disorders in personal injury
- Recognising and explaining functional neurological disorder
- Functional (psychogenic non-epileptic/dissociative) seizures: why and how?
- Functional symptoms in neurology: questions and answers
- Stress and functional neurological disorders: mechanistic insights
- ‘Cryptogenic Drop Attacks’ revisited: evidence of overlap with functional neurological disorder
- Decade of progress in motor functional neurological disorder: continuing the momentum
- Functional (conversion) neurological symptoms: research since the millennium
- Functional symptoms in neurology: mimics and chameleons